Screener
TG Therapeutics TGTX EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from TG Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
FAQ
- What is TG Therapeutics's EV / EBITDA?
- TG Therapeutics (TGTX) reported EV / EBITDA of 63.6× in Q2 2026.
- How has TG Therapeutics's EV / EBITDA changed year-over-year?
- TG Therapeutics's EV / EBITDA decreased by 9.6% year-over-year, from 70.4× to 63.6×.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.
Ask your AI about TG Therapeutics's ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude